WallStSmart

Copart Inc (CPRT)vsDolby Laboratories (DLB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Copart Inc generates 245% more annual revenue ($4.61B vs $1.34B). CPRT leads profitability with a 33.8% profit margin vs 18.0%. DLB appears more attractively valued with a PEG of 2.08. CPRT earns a higher WallStSmart Score of 53/100 (C-).

CPRT

Buy

53

out of 100

Grade: C-

Growth: 3.3Profit: 9.0Value: 4.7Quality: 7.3
Piotroski: 3/9Altman Z: 9.05

DLB

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 7.0Value: 7.3Quality: 7.3
Piotroski: 3/9Altman Z: 4.85
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPRTSignificantly Overvalued (-265.5%)

Margin of Safety

-265.5%

Fair Value

$10.81

Current Price

$33.08

$22.27 premium

UndervaluedFair: $10.81Overvalued
DLBSignificantly Overvalued (-311.3%)

Margin of Safety

-311.3%

Fair Value

$16.80

Current Price

$58.64

$41.84 premium

UndervaluedFair: $16.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPRT3 strengths · Avg: 10.0/10
Profit MarginProfitability
33.8%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
34.6%10/10

Strong operational efficiency at 34.6%

Altman Z-ScoreHealth
9.0510/10

Safe zone — low bankruptcy risk

DLB3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
4.8510/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Areas to Watch

CPRT4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.332/10

Expensive relative to growth rate

Revenue GrowthGrowth
-3.6%2/10

Revenue declined 3.6%

EPS GrowthGrowth
-10.0%2/10

Earnings declined 10.0%

DLB4 concerns · Avg: 2.8/10
PEG RatioValuation
2.084/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-2.9%2/10

Revenue declined 2.9%

EPS GrowthGrowth
-21.4%2/10

Earnings declined 21.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : CPRT

The strongest argument for CPRT centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 33.8% and operating margin at 34.6%.

Bull Case : DLB

The strongest argument for DLB centers on Altman Z-Score, Price/Book, Operating Margin. Profitability is solid with margins at 18.0% and operating margin at 20.9%.

Bear Case : CPRT

The primary concerns for CPRT are Piotroski F-Score, PEG Ratio, Revenue Growth.

Bear Case : DLB

The primary concerns for DLB are PEG Ratio, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

CPRT carries more volatility with a beta of 1.11 — expect wider price swings.

DLB is growing revenue faster at -2.9% — sustainability is the question.

CPRT generates stronger free cash flow (58M), providing more financial flexibility.

Monitor SPECIALTY BUSINESS SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CPRT scores higher overall (53/100 vs 48/100), backed by strong 33.8% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Copart Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Copart, Inc. or simply Copart is a global provider of online vehicle auction and remarketing services to automotive resellers such as insurance, rental car, fleet and finance companies in 11 countries: the US, Canada, the UK, Germany, Ireland, Brazil, Spain, Dubai, Bahrain, Oman and Finland.

Dolby Laboratories

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

Dolby Laboratories, Inc. creates imaging and audio technologies that transform entertainment and communications in the theater, home, work, and mobile devices. The company is headquartered in San Francisco, California.

Want to dig deeper into these stocks?